A detailed history of New Edge Wealth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New Edge Wealth, LLC holds 21,370 shares of BMY stock, worth $1.24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,370
Previous 317,835 93.28%
Holding current value
$1.24 Million
Previous $13.2 Million 91.63%
% of portfolio
0.02%
Previous 0.29%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $11.8 Million - $15.3 Million
-296,465 Reduced 93.28%
21,370 $1.11 Million
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $434,015 - $571,391
-10,783 Reduced 3.28%
317,835 $13.2 Million
Q1 2024

May 06, 2024

BUY
$47.98 - $54.4 $1.82 Million - $2.07 Million
37,979 Added 13.07%
328,618 $17.8 Million
Q4 2023

Jan 29, 2024

BUY
$48.48 - $57.85 $13.2 Million - $15.8 Million
273,220 Added 1568.52%
290,639 $14.9 Million
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $38,381 - $42,915
-663 Reduced 3.67%
17,419 $1.01 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $363,656 - $403,783
-5,708 Reduced 23.99%
18,082 $1.16 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $470,352 - $533,485
7,158 Added 43.04%
23,790 $1.65 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $103,747 - $122,851
1,515 Added 10.02%
16,632 $1.2 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $368 - $217,995
-2,837 Reduced 15.8%
15,117 $1.08 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $1.3 Million - $1.44 Million
17,954 New
17,954 $1.38 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track New Edge Wealth, LLC Portfolio

Follow New Edge Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.